AU2028601A - Arginine-enriched medium composition used for mass-producing recombinant proteinin animal cell culture - Google Patents

Arginine-enriched medium composition used for mass-producing recombinant proteinin animal cell culture

Info

Publication number
AU2028601A
AU2028601A AU20286/01A AU2028601A AU2028601A AU 2028601 A AU2028601 A AU 2028601A AU 20286/01 A AU20286/01 A AU 20286/01A AU 2028601 A AU2028601 A AU 2028601A AU 2028601 A AU2028601 A AU 2028601A
Authority
AU
Australia
Prior art keywords
proteinin
arginine
mass
cell culture
composition used
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20286/01A
Inventor
Joo Young Chung
Tae Kyung Kim
Gyun Min Lee
Seung Kook Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daewoong Pharmaceutical Co Ltd
Original Assignee
Daewoong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Pharmaceutical Co Ltd filed Critical Daewoong Pharmaceutical Co Ltd
Publication of AU2028601A publication Critical patent/AU2028601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/524—Thrombopoietin, i.e. C-MPL ligand
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU20286/01A 1999-12-15 2000-12-13 Arginine-enriched medium composition used for mass-producing recombinant proteinin animal cell culture Abandoned AU2028601A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1019990057910A KR20010056451A (en) 1999-12-15 1999-12-15 Arginine-enriched medium used for mass-producing recombinant protein in animal cell culture
KR9957910 1999-12-15
PCT/KR2000/001449 WO2001044442A1 (en) 1999-12-15 2000-12-13 Arginine-enriched medium composition used for mass-producing recombinant protein in animal cell culture

Publications (1)

Publication Number Publication Date
AU2028601A true AU2028601A (en) 2001-06-25

Family

ID=19626045

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20286/01A Abandoned AU2028601A (en) 1999-12-15 2000-12-13 Arginine-enriched medium composition used for mass-producing recombinant proteinin animal cell culture

Country Status (3)

Country Link
KR (1) KR20010056451A (en)
AU (1) AU2028601A (en)
WO (1) WO2001044442A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050070512A (en) * 2003-12-30 2005-07-07 삼성정밀화학 주식회사 Cell culture method and serum free meia for improved production of recombinant protein
CN100355880C (en) * 2004-11-19 2007-12-19 上海中科伍佰豪生物工程有限公司 Method for optimizing culture-medium of high-flux mammal
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US9475858B2 (en) 2011-07-08 2016-10-25 Momenta Pharmaceuticals, Inc. Cell culture process
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
SG11201504249XA (en) 2012-09-02 2015-07-30 Abbvie Inc Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
EP2830651A4 (en) 2013-03-12 2015-09-02 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
US8921526B2 (en) 2013-03-14 2014-12-30 Abbvie, Inc. Mutated anti-TNFα antibodies and methods of their use
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
CN103484426B (en) * 2013-10-15 2014-11-26 齐鲁制药有限公司 Non-animal source low-protein culture medium
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6251983A (en) * 1985-09-02 1987-03-06 Hagiwara Yoshihide Serum-free culture medium for cultivating human/human hybridoma
DD265425A1 (en) * 1985-09-04 1989-03-01 Friedrich Loeffler Inst Insel PROCESS FOR PRODUCING PH-VALUE OF STABLE CULTURAL MEDIA
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
FR2729972B1 (en) * 1995-01-31 1997-04-18 Sanofi Sa PROCESS FOR THE EXTRACTION OF PERIPLASMIC PROTEINS FROM PROKARYOTIC MICROORGANISMS IN THE PRESENCE OF ARGININ
WO1998004681A2 (en) * 1996-07-25 1998-02-05 Genzyme Corporation Chondrocyte media formulations and culture procedures

Also Published As

Publication number Publication date
WO2001044442A1 (en) 2001-06-21
KR20010056451A (en) 2001-07-04

Similar Documents

Publication Publication Date Title
AU2028601A (en) Arginine-enriched medium composition used for mass-producing recombinant proteinin animal cell culture
AU6311099A (en) Serum-free medium for culturing animal cells
AU2002230527A1 (en) Mailer for cell culture apparatus
EP1385933A4 (en) Culture medium for cell growth and transfection
AU2001294520A1 (en) Methods and compositions for increasing protein yield from a cell culture
AU4926899A (en) Hematopoietic cell composition for use in transplantation
AU5090200A (en) Culture chamber
AU1201600A (en) Controlling gene expression in living cells
AU5994900A (en) Compounds for inhibiting diseases and preparing cells for transplantation
AU2721200A (en) Culture medium using ballasted ph indicators
AU2001235452A1 (en) Cell culture media
EP0973867A4 (en) Cell culture media for enhanced protein production
AU6229498A (en) Composition for gene introduction into cell
AU4418699A (en) Artificial media for rearing entomophages
AU7371394A (en) Culture media additives for bioreactors
AU2878200A (en) Growth medium for human corneal endothelial cells
AU4697600A (en) Methods for increasing t cell proliferation
AU5061300A (en) Microchamber for embryo cell culture
AU2001275173A1 (en) Peptides for use in culture media
AU7017300A (en) Biological device, especially for cell culture
AU2306200A (en) Reference material for nucleic acid amplification
AU7494200A (en) Proteins associated with cell differentiation
AU7318700A (en) Novel transaldolase gene
AU2153401A (en) Gene expression in biological conditions
AU5148296A (en) Culture medium for insect cells

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase